Lenacapavir

SKU T11465-1 mg Category Small Compound Brand: TargetMol

Price range: 533 CAD through 4,752 CAD

Size

1 mg 10 mg 100 mg 25 mg 5 mg 50 mg

Clear

Products Details

Product Description

– Lenacapavir (GS-6207) is the first HIV-1 capsid inhibitor approved by the U.S. Food and Drug Administration, the European Medicines Agency, and Health Canada for the treatment of MDR HIV-1 infection.[3]

Web ID

– T11465

Storage Temperature

– -20℃

Shipping

– Blue Ice

Molecular Formula

– C39H32ClF10N7O5S2

Citations

– 1. Machine learning–enabled virtual screening indicates the anti-tuberculosis activity of aldoxorubicin and quarfloxin with verification by molecular docking, molecular dynamics simulations, and biological evaluations

References

– John O Link, et al. Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature. 2020 Jul 1.

CAS Number

– 2189684-44-2

Molecular Weight

– C39H32ClF10N7O5S2

Compound Purity

– 0.9961

SMILES

– [H][C@]12C[C@@]1([H])C(F)(F)c1c2c(nn1CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)c1nc(ccc1-c1ccc(Cl)c2c(NS(C)(=O)=O)nn(CC(F)(F)F)c12)C#CC(C)(C)S(C)(=O)=O)C(F)(F)F

Target

– p38 MAPK

Pathway

– Microbiology/Virology|||Proteases/Proteasome

Product type

– Small Compound

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

Lenacapavir

Products Details

POPULAR CATEGORIES

POPULAR PRODUCTS

Help & Support

Compare Products (0 Products)

Lenacapavir

Products Details

Related Products

Request Data Sheet / Safty Data Sheet

Price Request